Sequenom IPO Prospectus Shows Diagnostics Potential In Product Pipeline
This article was originally published in The Gray Sheet
Executive Summary
Potential applicability of Sequenom, Inc.' s industrial genomics technology to the field of diagnostics is outlined in a preliminary prospectus for an initial public offering of up to $70 mil. in common stock, recently filed with the Securities and Exchange Commission.